C3.ai, Inc.
-$495.10M- Market cap
- $36.61M
- Debt
- +$43.74M
- Cash
- −$575.45M
Capital structure 46% equity / 54% debt · EV / EBITDA 1.09x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: AI stock price at premium vs VNDA $10.46 current versus $2.71 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VNDA's multiple
Implied fair value · at AI's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: AI FY 2026 (ended Apr 30, 2026) · VNDA FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 46% equity / 54% debt · EV / EBITDA 1.09x
Capital structure 81% equity / 19% debt · EV / Revenue 1.49x
VNDA carries the larger enterprise value at $321.69M against -$495.10M.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
C3.ai, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
VANDA PHARMACEUTICALS INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.07x
0.24x
Net debt / EBITDA
Leverage against operating earnings
1.17x
0.05x
Cash and equivalents
Liquid reserves on the balance sheet
$575.45M
$84.85M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ORACLE CORP
AI vs ORCL
ServiceNow, Inc.
AI vs NOW
Palantir Technologies Inc.
AI vs PLTR
Snowflake Inc.
AI vs SNOW
UiPath, Inc.
AI vs PATH
PEGASYSTEMS INC
AI vs PEGA
SUPERNUS PHARMACEUTICALS, INC.
AI vs SUPN
CATALYST PHARMACEUTICALS, INC.
AI vs CPRX
Harmony Biosciences Holdings, Inc.
AI vs HRMY
ELI LILLY & Co
AI vs LLY
INCYTE CORP
AI vs INCY
Sarepta Therapeutics, Inc.
AI vs SRPT
$43.74M
$78.23M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.